Cell death pathway induced by resveratrol-bovine serum albumin nanoparticles in a human ovarian cell line

Oncology Letters

Volumn 9, Issue 3, 2015, Pages 1359-1363

  Guo, Liyuan ^a   Peng, Yan ^b   Li, Yulian ^a   Yao, Jingping ^b   Zhang, Guangmei ^a   Chen, Jie ^a   Wang, Jing ^a   Sui, Lihua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Caspase independent; Programmed cell death; Resveratrol bovine serum albumin nanoparticles

Indexed keywords

APOPTOSIS INDUCING FACTOR; BOVINE SERUM ALBUMIN; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; NANOPARTICLE; PROTEIN BAX; PROTEIN BCL 2; RESVERATROL;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; OVARY CANCER; WESTERN BLOTTING;

EID: 84921825032     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.2851     Document Type: Article

References (40)

1. Koul D, Shen R, Bergh S, Sheng X, Shishodia S, Lafortune TA, Lu Y, de Groot JF, Mills GB and Yung WK: Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma. Mol Cancer Ther 5: 637-644, 2006.
2. Harikumar KB and Aggarwal BB: Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7: 1020-1035, 2008.
3. Delmas D, Lançon A, Colin D, Jannin B and Latruffe N: Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 7: 423-442, 2006.
4. Kundu JK and Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269: 243-261, 2008.
5. Yang CS, Landau JM, Huang MT and Newmark HL: Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21: 381-406, 2001.
6. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
7. Tessitore L, Davit A, Sarotto I and Caderni G: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21: 1619-1622, 2000.
8. Hebbar V, Shen G, Hu R, Kim BR, Chen C, Korytko PJ, Crowell JA, Levine BS and Kong AN: Toxicogenomics of resveratrol in rat liver. Life Sci 76: 2299-2314, 2005.
9. Soleas GJ, Angelini M, Grass L, Diamandis EP and Goldberg DM: Absorption of trans-resveratrol in rats. Methods Enzymol 335: 145-154, 2001.
10. Singh G and Pai RS: In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration. J Pharm Pharmacol 66: 1062-1076, 2014.
11. Croy SR and Kwon GS: Polymeric micelles for drug delivery. Curr Pharm Des 12: 4669-4684, 2006.
12. Escorcia FE, McDevitt MR, Villa CH and Scheinberg DA: Targeted nanomaterials for radiotherapy. Nanomedicine (Lond) 2: 805-815, 2007.
13. Li F, Zhang X, Li H, Xiang L and Chen Y: Preparation of self-assembled nanoparticles of chitosan oligosaccharide-graft-polycaprolactone as a carrier of bovine serum albumin drug. Biomed Mater Eng 24: 2041-2048, 2014.
14. Yu Z, Yu M, Zhang Z, Hong G and Xiong Q: Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear. Nanoscale Res Lett 9: 343, 2014.
15. Guo LY, Yao JP and Sui LH: Preparation and Effects of Resveratrol-Bovine Serum Albumin Nanoparticles on Proliferation of Human Ovarian Carcinoma Cell SKOV3. Chemical Journal of Chinese Universities 30: 474-477, 2009.
16. Guo LY, Peng Y, Li YL, Yao JP, Wang J, Zhang GM, Chen J and Sui LH: Mechanisms of resveratrol-bovine serum albumin nanoparticle-induced cell death in human ovarian cancer SKOV3 cells. Nan Fang Yi Ke Da Xue Xue Bao 30: 2440-2442, 2010 (In Chinese).
17. Guo L, Peng Y, Yao J, Sui L, Gu A and Wang J: Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice. Cancer Biother Radiopharm 25: 471-477, 2010.
18. Anastasiadis PZ, Jiang H, Bezin L, Kuhn DM and Levine RA: Tetrahydrobiopterin enhances apoptotic PC12 cell death following withdrawal of trophic support. J Biol Chem 276: 9050-9058, 2001.
19. Jäättelä M: Programmed cell death: many ways for cells to die decently. Ann Med 34: 480-488, 2002.
20. Jäättelä M and Tschopp J: Caspase-independent cell death in T lymphocytes. Nat Immunol 4: 416-423, 2003.
21. Lorenzo HK and Susin SA: Mitochondrial effectors in caspase-independent cell death. FEBS Lett 557: 14-20, 2004.
22. Blagosklonny MV: Cell death beyond apoptosis. Leukemia 14: 1502-1508, 2000.
23. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-de Murcia J and Susin SA: Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol 27: 4844-4862, 2007.
24. Zanna C, Ghelli A, Porcelli AM, Martinuzzi A, Carelli V and Rugolo M: Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and Endonuclease G. Apoptosis 10: 997-1007, 2005.
25. Miyake K, Bekisz J, Zhao T, Clark CR and Zoon KC: Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells. Biochim Biophys Acta 1823: 1378-1388, 2012.
26. Zhan ZL and Chen LY: Changes in the expression of the apoptosis of esophageal cancer EC9706 cells during nuclear matrix proteins induced by curcumin. Zhong Guo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao 546-555, 2010
27. Wu B,Gao Q: Microscope laser cytoskeleton changes in the process of cell apoptosis confocal. Dian Zi Xian Wei Xue Bao 361-366, 2010
28. Byun HS, Song JK, Kim YR, Piao L, Won M, Park KA, Choi BL, Lee H, Hong JH, Park J, et al: Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47: 301-308, 2008.
29. Arnoult D, Parone P, Martinou JC, Antonsson B, Estaquier J and Ameisen JC: Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 159: 923-929, 2002.
30. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G and Slack RS: Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158: 507-517, 2002.
31. Bröker LE, Kruyt FA and Giaccone G: Cell death independent of caspases: a review. Clin Cancer Res 11: 3155-3162, 2005.
32. Hall JB, Dobrovolskaia MA, Patri AK and McNeil SE: Characterization of nanoparticles for therapeutics. Nanomedicine (Lond) 2: 789-803, 2007.
33. Dorrie J, Gerauer H, Wachter Y and Zunino SJ: Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 61: 4731-4739, 2001.
34. Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, Kofler R, Csordas A and Greil R: Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J 15: 1613-1615, 2001.
35. Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, Sun YY, Hudson EA and Manson MM: Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 28: 1274-1304, 2007.
36. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR and Kim AL: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283, 2007.
37. Pervaiz S: Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist Updat 7: 333-344, 2004.
38. Signorelli P and Ghidoni R: Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16: 449-466, 2005.
39. Le Corre L, Chalabi N, Delort L, Bignon YJ and Bernard-Gallon DJ: Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol Nutr Food Res 49: 462-471, 2005.
40. Sheridan C, Delivani P, Cullen SP and Martin SJ: Bax-or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol Cell 31: 570-585, 2008.